Venlafaxine Hydrochloride
Product Images NDC 50090-2886

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-2886). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 01

E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 01
This text appears to be a table of interactions between certain drugs and analytes, specifically related to CYP2D6 EM's and PM's. The table also includes PK Fold Change and 90% C recommendations, suggesting whether dose adjustment or caution is necessary when taking the drug with the analyte. Not much else can be inferred without further context.*
FDA Label Image

E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 02

E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 02
This is a list of drugs and their interaction with other drugs. The list consists of ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, and lithium. The table provides information about the Analyte PKFold change and 90% CRecommendation. The table mentions Cmax, Auc, and their dose adjustments. Footnotes are available for specific drug interactions.*
FDA Label Image

E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 03

E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 03
This is a document that highlights the recommendations for dose adjustments of the drug Venlafaxine for patients with specific medical conditions such as hepatic impairment, renal impairment, CYP2D8 polymorphism, age above 80 years, and gender. The document shows the fold change and 90% CI of the analyte and suggests the necessary dose adjustments for each medical condition. However, there seem to be typos and errors in the text, making it difficult to interpret some parts of the information.*
FDA Label Image

E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 04

E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 04
The description will be: "eHCI H4C0 C" doesn't provide any meaningful information. "venlafaxine hydrochloride" is a medication used to treat depression, anxiety, and panic attacks."*
FDA Label Image

Label Image (Lbl500902886)

FDA Label Image

Label Image (Lbl500902894)

Label Image (Lbl500902894)
This is a description of a medication in the form of extended-release capsules with the product number 9852-0. The capsules are 25 unit dose and contain HYDROCHLORIDE. The rest of the text is not clearly readable and may have resulted from an error during the scanning process.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.